@Geovax_News@FIFAcom Timely discussion ahead of 2026.
Curious—what specific biodefense and surveillance measures are being prioritized most for event readiness?
@tevapharmeurope Personalized approaches in multiple sclerosis care are essential, especially as patient populations become more complex and heterogeneous.
@Biotech_Spain@NeuroAlc Very promising findings.
Curious—what specific brain immune pathways does this experimental molecule target to achieve its effects?
@OSTherapies Encouraging results. Improvements in overall survival for patients with metastatic osteosarcoma represent an important step forward in addressing a significant unmet need.
@HaemaLogiX Exciting progress for the KOALA trial. Continued innovation in CAR T-cell therapy offers promising potential for patients with multiple myeloma.
@OraBiomedical The combination of AI-driven drug discovery and geroscience holds exciting potential for extending healthspan and addressing age-related diseases.
@psilera An oversubscribed seed round reflects strong confidence in the potential of novel approaches targeting neurological and mental health disorders.